Intravascular B-cell lymphoma diagnosed by skin biopsy

Australasian Journal of Dermatology

Volumn 46, Issue 4, 2005, Pages 261-265

  Le, Katie ^a   Lim, Adrian ^a   Bullpitt, Peter ^a   Wood, Glenda ^a  

^a PRINCE OF WALES HOSPITAL   (Australia)

Author keywords

CHOP; Cutaneous lymphoma; Diffuse large B cell non Hodgkin's lymphoma; Haemophagocytic syndrome; Rituximab

Indexed keywords

CEFTRIAXONE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DOXORUBICIN; HEPARIN; MOXIFLOXACIN; PREDNISONE; VINCRISTINE; WARFARIN; ANTINEOPLASTIC AGENT; PREDNISOLONE; VAP CYCLO PROTOCOL; VAP-CYCLO PROTOCOL;

ADULT; ARTICLE; B CELL LYMPHOMA; BONE MARROW BIOPSY; CANCER COMBINATION CHEMOTHERAPY; CANCER REGRESSION; CASE REPORT; CLINICAL FEATURE; COMMUNITY ACQUIRED PNEUMONIA; ERYTHEMA; ERYTHROPHAGOCYTOSIS; FEVER; GENERALIZED EDEMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTRAVASCULAR B CELL LYMPHOMA; LUNG EMBOLISM; MALE; MULTIPLE ORGAN FAILURE; RESPIRATORY FAILURE; SKIN BIOPSY; SKIN INDURATION; SKIN MANIFESTATION; THROMBOCYTOPENIA; VASCULAR TUMOR; ABDOMEN; AMYLOIDOSIS; DIFFERENTIAL DIAGNOSIS; MIDDLE AGED; PATHOLOGY; SKIN DISEASE; TREATMENT OUTCOME;

ABDOMEN; AMYLOIDOSIS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CYCLOPHOSPHAMIDE; DIAGNOSIS, DIFFERENTIAL; DOXORUBICIN; FEVER; HUMANS; LYMPHOMA, B-CELL; MALE; MIDDLE AGED; PREDNISOLONE; RESPIRATORY INSUFFICIENCY; SKIN DISEASES; TREATMENT OUTCOME; VINCRISTINE;

EID: 33644839464     PISSN: 00048380     EISSN: 14400960     Source Type: Journal    
DOI: 10.1111/j.1440-0960.2005.00197.x     Document Type: Article

References (18)

1. Sterry W, Muche JM. Other systemic lymphomas with skin infiltrate. In: Freedberg IM, Eisen AZ, Wolff K, Austin KF, Goldsmith LA, Katz SI (eds). Fitzpatrick's Dermatology in General Medicine, 6th edn. New York : McGraw-Hill, 2003 1558 66.
2. Russell-Jones R. World Health Organization classification of hematopoietic and lymphoid tissues: implications for dermatology. J. Am. Acad. Dermatol. 2003 48 : 93 102.
3. Ferreri AJM, Campo E, Seymour J, Willemze R, Ilariucci F, Ambrosetti A et al. Intravascular lymphoma: clinical presentation, natural history, management and prognostic factors in a series of 38 cases, with special emphasis on the cutaneous variant. Br. J. Haematol. 2004 127 : 173 83.
4. Eros N, Karolyi Z, Kovacs A, Takacs I, Radvanyi G, Kelenyi G. Intravascular B cell lymphoma. J. Am. Acad. Dermatol. 2002 47 : S260 2.
5. Willemze R, Kerl H, Sterry W, Berti E, Cerroni L, Chimenti S et al. EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer. Blood 1997 90 : 354 71.
6. Gill S, Melosky B, Haley L, ChanYan C. Use of random skin biopsy to diagnose intravascular lymphoma presenting as fever of unknown origin. Am. J. Med. 2003 114 : 56 8.
7. Demirer T, Dail D, Aboulafia M. Four varied cases of intravascular lymphomatosis and a literature review. Cancer 1994 73 : 1738 45.
8. Khoury H, Lestou V, Gascoyne R, Bruyere H, Li C. Multicolour karyotyping and clinicopathological analysis of three intravascular lymphoma cases. Mod. Pathol. 2003 16 : 716 24.
9. Ganeshan A, Soonawalla Z, De M, Baxter J. Intravascular lymphoma: a diagnostic enigma. J. R. Soc. Med. 2002 95 : 37 8.
10. Yalamanchili M, Prabhu S, Bradstreet P, Chouhdry I, Walsh J. Intravascular lymphomatosis presenting as systemic inflammatory response. Am. J. Med. Sci. 2002 324 : 339 41.
11. Fozza C, Bonfigli S, Conti M, Dore F, Longinotti M. Long-lasting fever of unknown origin preceding the diagnosis of intravascular lymphomatosis: a further case stimulates some remarks. Am. J. Hematol. 2003 74 : 211 13.
12. Stroup RM, Sheibani K, Moncada A, Purdy LJ, Battifora H. Angiotropic (intravascular) large cell lymphoma: a clinicopathological study of seven cases with unique clinical presentations. Cancer 1990 66 : 1781 8.
13. Bhagwati NS, Oiseth SJ, Abebe LS, Weirnik PH. Intravascular lymphoma associated with hemophagocytic syndrome: a rare but aggressive clinical entity. Ann. Hematol. 2004 83 : 247 50.
14. Murase T, Nakamura S, Tashiro K, Suchi T, Hiraga J, Hayasaki N et al. Malignant histiocytosis-like B-cell lymphoma, a distinct pathologic variant of intravascular lymphomatosis: a report of five cases and review of the literature. Br. J. Haematol. 1997 99 : 656 64.
15. DiGuiuseppe JA, Nelson WG, Seifter EJ, Boitnott JK, Mann RB. Intravascular lymphomatosis: a clinicopathologic study of 10 cases and assessment of response to chemotherapy. J. Clin. Oncol. 1994 12 : 2573 9.
16. Pettengell R, Linch D. Position paper on the therapeutic use of rituximab in CD20-positive diffuse large B-cell non-Hodgkin's lymphoma. Br. J. Haematol. 2003 121 : 44.
17. Coiffier B, Lepage E, Briere J, Herbrecht R, Tilly H, Bouabdalla R et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patient with diffuse large B-cell lymphoma. N. Engl. J. Med. 2002 346 : 235 42.
18. Pfeundschuh M, Truemper L, Gill D, Osterberg A, Pettengell R, Tmeny M, Imrie K, Walewski J, Zinzani P, Loeffler M. First analysis of the completed Mabthera International Trial (MInT) in young patients with low risk large B cell lymphoma (DLBCL): addition of rituximab to a CHOP like regime significantly improves outcome of all patients with the identification of a favorable subgroup with IPI = 0 and no bulky disease. Abstract presented at the 46th Annual American Society of Hematology Meeting, December 2004. Available from URL: http://www.hematology.org/meeting/abstracts.cfm (Accessed 21 Apr 2005).